Episodes

  • GLP-1 Muscle Loss — The Hidden Risk - The Race to Build a Better Drug

    GLP-1 Muscle Loss — The Hidden Risk - The Race to Build a Better Drug
    Apr 7 2026
    Host Ben Synth explores groundbreaking research on GLP-1 weight loss drugs and muscle preservation. He examines the BELIEVE study combining semaglutide with bimagrumab, which achieved 92.8% fat loss versus lean tissue loss, and discusses revolutionary continuous biosensor technology tracking muscle breakdown in real-time for patients on medications like Ozempic and Mounjaro.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Show More Show Less
    25 mins
  • GLP-1 Muscle Loss — The Hidden Risk - Bimagrumab, Biosensors, and Smarter Weight Loss

    GLP-1 Muscle Loss — The Hidden Risk - Bimagrumab, Biosensors, and Smarter Weight Loss
    Apr 7 2026
    Ben Synth explores groundbreaking research combining semaglutide with bimagrumab, which produced 22% weight loss—93% from fat while preserving muscle. Plus, emerging wearable sensors could soon monitor muscle breakdown in real-time, revolutionizing how we approach GLP-1 therapy and body composition.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Show More Show Less
    28 mins